Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
46.67
-0.75 (-1.58%)
At close: Dec 5, 2025, 4:00 PM EST
46.60
-0.07 (-0.15%)
After-hours: Dec 5, 2025, 5:48 PM EST
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $4.43 billion as of December 5, 2025. Its market cap has decreased by -11.07% in one year.
Market Cap
4.43B
Enterprise Value
3.39B
1-Year Change
-11.07%
Ranking
Category
Stock Price
$46.67
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $4.43B, an increase of 685.32%. That is a compound annual growth rate of 32.18%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |